LUPIN RESEARCH INC

Company Introduction for LUPIN RESEARCH INC

LUPIN RESEARCH INC is the dedicated research and development (R&D) arm of Lupin Limited, a global pharmaceutical company headquartered in Mumbai, India.

Factory or Trader:

LUPIN RESEARCH INC is neither a factory (manufacturer of finished goods) nor a pure trader. It is a research and development organization. Its primary function is to conduct advanced research in pharmaceuticals, including drug discovery, development of new chemical entities (NCEs), generic drug development, biosimilars, and novel drug delivery systems. This R&D work directly supports the manufacturing and commercialization activities of its parent company, Lupin Limited, which is a major pharmaceutical manufacturer. Therefore, while not a factory itself, its operations are intrinsically linked to and foundational for pharmaceutical manufacturing.

Company Overview:

LUPIN RESEARCH INC is focused on innovation and scientific excellence to develop a pipeline of high-quality, affordable medicines. It plays a crucial role in Lupin Limited's strategy to expand its product portfolio and market presence across various therapeutic areas globally. The company employs a team of highly skilled scientists and researchers working in state-of-the-art facilities. Its contributions include developing complex generics, specialty products, and biosimilars, which are then manufactured and distributed by Lupin Limited. The research efforts span across multiple therapeutic segments such as cardiovascular, diabetology, respiratory, pediatrics, anti-infectives, and women's health.

Lupin Research Inc., as a part of Lupin Limited, is involved in the research, development, manufacturing, and sale of a diverse portfolio of pharmaceutical products globally, including in the United States. Their product offerings primarily include:

Generic Pharmaceuticals

These are bioequivalent copies of brand-name drugs, offering cost-effective treatment options across various therapeutic categories.

Branded Generics

These are generic drugs marketed under a brand name, often with additional features or unique formulations, primarily in emerging markets.

Active Pharmaceutical Ingredients (APIs)

Lupin manufactures and supplies the key active ingredients used in the production of finished pharmaceutical products to other manufacturers worldwide.

Biosimilars

These are biological products highly similar to an already approved biological product (reference product) and have no clinically meaningful differences from the reference product.

Over-the-Counter (OTC) Products

A range of non-prescription medicines for common ailments.

These products address a wide range of therapeutic areas such as:

Cardiovascular Diseases

Central Nervous System Disorders

Anti-Infectives

Diabetes

Respiratory Conditions

Women's Health

Gastrointestinal Disorders

Oncology

Pediatrics

Pain Management